Drug Profile
Research programme: inflammasome modulators - KinDex Pharmaceuticals
Alternative Names: KDT 600Latest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator KinDex Pharmaceuticals
- Class Small molecules
- Mechanism of Action Inflammasome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for research development in Inflammation in USA
- 28 Apr 2018 No recent reports of development identified for research development in Obesity in USA
- 28 Apr 2018 No recent reports of development identified for research development in Type-2-diabetes-mellitus in USA